156 related articles for article (PubMed ID: 26496950)
1. OpenTein: a database of digital whole-slide images of stem cell-derived teratomas.
Park SJ; Komiyama Y; Suemori H; Umezawa A; Nakai K
Nucleic Acids Res; 2016 Jan; 44(D1):D1000-4. PubMed ID: 26496950
[TBL] [Abstract][Full Text] [Related]
2. Teratoma formation of human embryonic stem cells in three-dimensional perfusion culture bioreactors.
Stachelscheid H; Wulf-Goldenberg A; Eckert K; Jensen J; Edsbagge J; Björquist P; Rivero M; Strehl R; Jozefczuk J; Prigione A; Adjaye J; Urbaniak T; Bussmann P; Zeilinger K; Gerlach JC
J Tissue Eng Regen Med; 2013 Sep; 7(9):729-41. PubMed ID: 22438087
[TBL] [Abstract][Full Text] [Related]
3. Teratoma formation by human embryonic stem cells: evaluation of essential parameters for future safety studies.
Hentze H; Soong PL; Wang ST; Phillips BW; Putti TC; Dunn NR
Stem Cell Res; 2009 May; 2(3):198-210. PubMed ID: 19393593
[TBL] [Abstract][Full Text] [Related]
4. Development of experimental tumors formed by mouse and human embryonic stem and teratocarcinoma cells after subcutaneous and intraperitoneal transplantations into immunodeficient and immunocompetent mice.
Gordeeva OF; Nikonova TM
Cell Transplant; 2013; 22(10):1901-14. PubMed ID: 23051679
[TBL] [Abstract][Full Text] [Related]
5. Bioluminescence reporter gene imaging characterize human embryonic stem cell-derived teratoma formation.
Su W; Zhou M; Zheng Y; Fan Y; Wang L; Han Z; Kong D; Zhao RC; Wu JC; Xiang R; Li Z
J Cell Biochem; 2011 Mar; 112(3):840-8. PubMed ID: 21328457
[TBL] [Abstract][Full Text] [Related]
6. Reversible transformation and de-differentiation of human cells derived from induced pluripotent stem cell teratomas.
Kamada M; Mitsui Y; Matsuo T; Takahashi T
Hum Cell; 2016 Jan; 29(1):1-9. PubMed ID: 26069211
[TBL] [Abstract][Full Text] [Related]
7. Human induced pluripotent stem cells develop teratoma more efficiently and faster than human embryonic stem cells regardless the site of injection.
Gutierrez-Aranda I; Ramos-Mejia V; Bueno C; Munoz-Lopez M; Real PJ; Mácia A; Sanchez L; Ligero G; Garcia-Parez JL; Menendez P
Stem Cells; 2010 Sep; 28(9):1568-70. PubMed ID: 20641038
[No Abstract] [Full Text] [Related]
8. Teratoma: from spontaneous tumors to the pluripotency/malignancy assay.
Bulic-Jakus F; Katusic Bojanac A; Juric-Lekic G; Vlahovic M; Sincic N
Wiley Interdiscip Rev Dev Biol; 2016; 5(2):186-209. PubMed ID: 26698368
[TBL] [Abstract][Full Text] [Related]
9. Teratoma Assay for Testing Pluripotency and Malignancy of Stem Cells: Insufficient Reporting and Uptake of Animal-Free Methods-A Systematic Review.
Montilla-Rojo J; Bialecka M; Wever KE; Mummery CL; Looijenga LHJ; Roelen BAJ; Salvatori DCF
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835305
[TBL] [Abstract][Full Text] [Related]
10. MIF produced by bone marrow-derived macrophages contributes to teratoma progression after embryonic stem cell transplantation.
Wang X; Chen T; Leng L; Fan J; Cao K; Duan Z; Zhang X; Shao C; Wu M; Tadmori I; Li T; Liang L; Sun D; Zheng S; Meinhardt A; Young W; Bucala R; Ren Y
Cancer Res; 2012 Jun; 72(11):2867-78. PubMed ID: 22461508
[TBL] [Abstract][Full Text] [Related]
11. TeratoScore: Assessing the Differentiation Potential of Human Pluripotent Stem Cells by Quantitative Expression Analysis of Teratomas.
Avior Y; Biancotti JC; Benvenisty N
Stem Cell Reports; 2015 Jun; 4(6):967-74. PubMed ID: 26070610
[TBL] [Abstract][Full Text] [Related]
12. Tumorigenicity of pluripotent stem cells: biological insights from molecular imaging.
Kooreman NG; Wu JC
J R Soc Interface; 2010 Dec; 7 Suppl 6(Suppl 6):S753-63. PubMed ID: 20880852
[TBL] [Abstract][Full Text] [Related]
13. Preventing Pluripotent Cell Teratoma in Regenerative Medicine Applied to Hematology Disorders.
Bedel A; Beliveau F; Lamrissi-Garcia I; Rousseau B; Moranvillier I; Rucheton B; Guyonnet-Dupérat V; Cardinaud B; de Verneuil H; Moreau-Gaudry F; Dabernat S
Stem Cells Transl Med; 2017 Feb; 6(2):382-393. PubMed ID: 28191782
[TBL] [Abstract][Full Text] [Related]
14. Is teratoma formation in stem cell research a characterization tool or a window to developmental biology?
Aleckovic M; Simón C
Reprod Biomed Online; 2008 Aug; 17(2):270-80. PubMed ID: 18682004
[TBL] [Abstract][Full Text] [Related]
15. Aurora-A overexpression is linked to development of aggressive teratomas derived from human iPS cells.
Ohmine S; Salisbury JL; Ingle J; Pettinato G; Haddox CL; Haddad T; Galanis E; Ikeda Y; D'assoro AB
Oncol Rep; 2018 Apr; 39(4):1725-1730. PubMed ID: 29393405
[TBL] [Abstract][Full Text] [Related]
16. Semiquantitative histopathology and 3D magnetic resonance microscopy as collaborative platforms for tissue identification and comparison within teratomas derived from pedigreed primate embryonic stem cells.
Castro CA; Ben-Yehudah A; Ozolek JA; Mills PH; Redinger CJ; Mich-Basso JD; McFarland DA; Oliver SL; Ahrens ET; Schatten G
Stem Cell Res; 2010 Nov; 5(3):201-11. PubMed ID: 20864427
[TBL] [Abstract][Full Text] [Related]
17. Murine pluripotent stem cells that escape differentiation inside teratomas maintain pluripotency.
Pei Y; Yue L; Zhang W; Xiang J; Ma Z; Han J
PeerJ; 2018; 6():e4177. PubMed ID: 29312817
[TBL] [Abstract][Full Text] [Related]
18. Compact MRI for the detection of teratoma development following intrathecal human embryonic stem cell injection in NOD-SCID mice.
Ramot Y; Schiffenbauer YS; Amouyal N; Ezov N; Steiner M; Izrael M; Lavon N; Hasson A; Revel M; Nyska A
Neurotoxicology; 2017 Mar; 59():27-32. PubMed ID: 28069364
[TBL] [Abstract][Full Text] [Related]
19. Direct
Xiang M; Lu M; Quan J; Xu M; Meng D; Cui A; Li N; Liu Y; Lu P; Kang X; Wang X; Sun N; Zhao M; Liang Q; Le L; Wang X; Zhang J; Chen S
Theranostics; 2019; 9(1):290-310. PubMed ID: 30662568
[TBL] [Abstract][Full Text] [Related]
20. Teratomas produced from human pluripotent stem cells xenografted into immunodeficient mice - a histopathology atlas.
Damjanov I; Andrews PW
Int J Dev Biol; 2016; 60(10-11-12):337-419. PubMed ID: 28000905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
